Accueil CHUV
Navigation menu

Centre des tumeurs neuroendocrines

Publications

Les intervenants du Centre des tumeurs neuroendocrines publient chaque année les résultats de leurs travaux de recherches dans diverses revues suisses et internationales.

2020

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.

Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, Guaraldi F, Hickman RA, Ikeda H, Jaffrain-Rea ML, Karavitaki N, Kraljević I, La Rosa S, Manojlović-Gačić E, Ma

Pituitary. 2019 Dec 13

Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.

Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Bezerra ROF, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Scaefer N, Baudin E, Sundin A, Costa F, Pavel M, Dromain C

Clin Cancer Res. 2019 Nov 15;25(22):6692-6699

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Franca Bezerra RO, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Sundin A, Costa F, Pavel M, Dromain C, Knowledge Network.

Oncologist. 2019 Nov;24(11):e1082-e1090

ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature.

La Rosa S, Volante M, Uccella S, Maragliano R, Rapa I, Rotolo N, Inzani F, Siciliani A, Granone P, Rindi G, Dominioni L, Capella C, Papotti M, Sessa F, Imperatori A

Virchows Arch. 2019 Nov;475(5):587-597

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.

Terroir M, Caramella C, Borget I, Bidault S, Dromain C, El Farsaoui K, Deandreis D, Grimaldi S, Lumbroso J, Berdelou A, Hadoux J, Hescot S, Hartl D, Baudin E, Schlumberger M, Leboulleux S

Thyroid. 2019 Oct;29(10):1457-1464

Comprehensive Evaluation of Rare Pituitary Lesions: A Single Tertiary Care Pituitary Center Experience and Review of the Literature.

Cossu G, Brouland JP, La Rosa S, Camponovo C, Viaroli E, Daniel RT, Messerer M

Endocr Pathol. 2019 Sep;30(3):219-236

PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters.

Ricci C, Morandi L, Righi A, Gibertoni D, Maletta F, Ambrosi F, Agostinelli C, Uccella S, Asioli S, Sessa F, Pellilli M, Maragliano R, La Rosa S, Papotti MG, Asioli S

Mod Pathol. 2019 Sep;32(9):1359-1372

Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature.

Uccella S, Amaglio C, Brouland JP, Bianconi E, Ippolito S, Messerer M, Rouiller N, Tanda ML, Sessa F, La Rosa S

Virchows Arch. 2019 Sep;475(3):373-381

Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.

Vanoli A, Albarello L, Uncini S, Fassan M, Grillo F, Di Sabatino A, Martino M, Pasquali C, Milanetto AC, Falconi M, Partelli S, Doglioni C, Schiavo-Lena M, Brambilla T, Pietrabissa A, Sessa F, Capella C, Rindi G, La Rosa S, Solcia E, Paulli M

Am J Surg Pathol. 2019 Jun;43(6):725-736

Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.

Saglietti C, La Rosa S, Sykiotis GP, Letovanec I, Bulliard JL, Piana S, Mermod M, Petrova T, Uccella S, Sessa F, Bongiovanni M

Endocr Pathol. 2019 Jun;30(2):138-145

CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Sciarra A, Monteiro I, Ménétrier-Caux C, Caux C, Gilbert B, Halkic N, La Rosa S, Romero P, Sempoux C, de Leval L

Cancer Immunol Immunother. 2019 Mar;68(3):467-478

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.

Dromain C, Pavel ME, Ruszniewski P, Langley A, Massien C, Baudin E, Caplin ME, CLARINET Study Group.

BMC Cancer. 2019 Jan 14;19(1):66

Gastric neuroendocrine neoplasms.

La Rosa S, Rindi G, Solcia E, Tang LH

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 104-109

Classification of neuroendocrine neoplasms of the digestive system.

Klimstra DS, Klöppel G, La Rosa S, Rindi G

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 16-19

VIPoma.

Shi C, Kasajima A, La Rosa S

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 357-358

Pancreatic neuroendocrine neoplasms: introduction.

Klöppel G, Adsay NV, Couvelard A, Hruban RH, Kasajima A, Klimstra DS, La Rosa S, Perren A, Rindi G, Sasano H, Scarpa A, Shi C, Singhi AD

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 343-346

Pituitary Tumors: Pathology and Genetics.

La Rosa S, Uccella S

Boffetta P, Hainaut P (eds.). Encyclopedia of Cancer, 3rd edition, vol. 3. Elsevier, Academic Press, 2019, pp 241–256

Pancreatic MiNENs.

La Rosa S, Klimstra DS

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 370-372

ACTH-producing neuroendocrine tumour.

La Rosa S, Rindi G

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 363-364

Neuroendocrine neoplasms of the gallbladder and bile ducts.

Adsay NV, La Rosa S

Carneiro F, Chan JKC, Cheung NYA, et al. (eds). WHO Classification of tumours, 5th Edition. Digestive system tumours. Lyon, IARC Press, 2019, pp 292-294

Mixed Adenoma Well-differentiated Neuroendocrine Tumor (MANET) of the Digestive System: An Indolent Subtype of Mixed Neuroendocrine-NonNeuroendocrine Neoplasm (MiNEN).

La Rosa S, Uccella S, Molinari F, Savio A, Mete O, Vanoli A, Maragliano R, Frattini M, Mazzucchelli L, Sessa F, Bongiovanni M

Am J Surg Pathol. 2018 Nov;42(11):1503-1512

Endocrine and neuroendocrine cytopathology.

Bongiovanni M, La Rosa S, Sykiotis GP

Minerva Endocrinol. 2018 Sep;43(3):294-304

Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Tract in Long-Standing Ulcerative Colitis: Report of a Case and Review of the Literature.

Bolzacchini E, Chini C, Cortelezzi CC, Vallini I, Pinotti G, La Rosa S, Uccella S

Int J Surg Pathol. 2018 Aug;26(5):479-483

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study.

Brighi N, La Rosa S, Rossi G, Grillo F, Pusceddu S, Rinzivillo M, Spada F, Tafuto S, Massironi S, Faggiano A, Antonuzzo L, Santini D, Sessa F, Maragliano R, Gelsomino F, Albertelli M, Vernieri C, Panzuto F, Fazio N, De Divitiis C, Lamberti G, Colao A, Fav

Ann Surg. 2018 Jul 10

The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.

Partelli S, Javed AA, Andreasi V, He J, Muffatti F, Weiss MJ, Sessa F, La Rosa S, Doglioni C, Zamboni G, Wolfgang CL, Falconi M

Eur J Surg Oncol. 2018 Jun;44(6):778-783

Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Uccella S, La Rosa S, Volante M, Papotti M

Endocr Pathol. 2018 Jun;29(2):150-168

Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis.

Milione M, Maisonneuve P, Pellegrinelli A, Grillo F, Albarello L, Spaggiari P, Vanoli A, Tagliabue G, Pisa E, Messerini L, Centonze G, Inzani F, Scarpa A, Papotti M, Volante M, Sessa F, Fazio N, Pruneri G, Rindi G, Solcia E, La Rosa S, Capella C

Endocr Relat Cancer. 2018 May;25(5):583-593

Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Klöppel G, La Rosa S

Virchows Arch. 2018 Mar;472(3):341-349

Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.

Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E

Neuroendocrinology. 2018;107(2):114-126

Pathology of neuroendocrine neoplasms: morphological, immunophenotypical, and circulating molecular markers

La Rosa S, Bongiovanni M, Uccella S

Giovanella L (ed). Atlas of thyroid and neuroendocrine tumor markers. Springer, 2018, pp 13-38

Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S,

Neuroendocrinology. 2018;107(4):375-386

Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.

Uccella S, Blank A, Maragliano R, Sessa F, Perren A, La Rosa S

Endocr Pathol. 2017 Dec;28(4):351-361

Are we reproducible in measurement of NET liver metastasis?

Moalla S, Arfi Rouche J, Foulon S, Caramella C, Ternes N, Planchard D, Goere D, Ducreux M, Scoazec JY, Deschamps F, Dromain C, Baudin E

Dig Liver Dis. 2017 Oct;49(10):1121-1127

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Fabbri A, Cossa M, Sonzogni A, Bidoli P, Canova S, Cortinovis D, Abbate MI, Calabrese F, Nannini N, Lunardi F, Rossi G, La Rosa S, Capella C, Tamborini E, Perrone F, Busico A, Capone I, Valeri B, Pastorino U, Albini A, Pelosi G

Virchows Arch. 2017 Jul;471(1):31-47

Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

Sahu S, Schernthaner R, Ardon R, Chapiro J, Zhao Y, Sohn JH, Fleckenstein F, Lin M, Geschwind JF, Duran R

Radiology. 2017 Jun;283(3):883-894

Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification.

Uccella S, Ottini G, Facco C, Maragliano R, Asioli S, Sessa F, La Rosa S

Pathologica. 2017 Mar;109(1):14-30

Pancreatic neuroendocrine tumors: update on the new World Health Organization classification

Klöppel G, Klimstra DS, Hruban RH, Adsay V, Capella C, Couvelard A, Komminoth P, La Rosa S, Ohike N, Osamura RY, Perren A, Scoazec JY, Rindi G

AJSP: Reviews and Reports 22:233-239,2017

Cohexisting medullary and papillary thyroid cancer

Dionigi G, Tanda ML, Piantanida E, Uccella S, La Rosa S, Inversini D, Lavazza M, Pappalardo V, Sessa F, Xiaoli L

J Endocr Surg 17:57-62

Non-functioning (non-syndromic) neuroendocrine tumours

Klimstra DS, Klöppel G, Couvelard A, Hruban R, Komminoth P, La Rosa S, Osamura RY, Perren A, Rindi G

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds). WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 215-221.

Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.

Vanoli A, La Rosa S, Klersy C, Grillo F, Albarello L, Inzani F, Maragliano R, Manca R, Luinetti O, Milione M, Doglioni C, Rindi G, Capella C, Solcia E

Neuroendocrinology. 2017;104(2):112-125

Insulinoma

Perren A, Anlauf M, Klimstra DS, Klöppel G, Komminoth P, La Rosa S, Öberg K, Scarpa A, Scoazec JY, Speel EJ, Zamboni G

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds). WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 222-224

The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.

Milione M, Maisonneuve P, Spada F, Pellegrinelli A, Spaggiari P, Albarello L, Pisa E, Barberis M, Vanoli A, Buzzoni R, Pusceddu S, Concas L, Sessa F, Solcia E, Capella C, Fazio N, La Rosa S

Neuroendocrinology. 2017;104(1):85-93

Somatostatinoma

La Rosa S, Komminoth P, Öberg K, Perren A

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds). WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 227-228

VIPoma

Capella C, La Rosa S, Öberg K, Papotti M, Speel EJ

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds). WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 231-232

ACTH producing tumour with Cushing syndrome

Osamura RY, La Rosa S, Öberg K, Perren A

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds) WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 234

Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNEN)

Ohike N, Adsay NV, La Rosa S, Volante M, Zamboni G

Lloyd RV, Osamura RB, Rosai J, Klöppel G (eds). WHO Classification of Tumours of Endocrine Organs, 4th edition. Lyon, IARC Press, 2017, pp 238-239

Breast metastasis as the first clinical manifestation of ileal neuroendocrine tumor. A challenging diagnosis with relevant clinical implications.

La Rosa S, Casnedi S, Maragliano R, Goyault G, Weber JC, Louis B, Schlund E, Sessa F

Endocr Pathol. 2015 May;26(2):145-51

Republished: gastric neuroendocrine neoplasms and related precursor lesions.

La Rosa S, Vanoli A

Postgrad Med J. 2015 Mar;91(1073):163-73

ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature.

Maragliano R, Vanoli A, Albarello L, Milione M, Basturk O, Klimstra DS, Wachtel A, Uccella S, Vicari E, Milesi M, Davì MV, Scarpa A, Sessa F, Capella C, La Rosa S

Am J Surg Pathol. 2015 Mar;39(3):374-82

Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.

Sahnane N, Furlan D, Monti M, Romualdi C, Vanoli A, Vicari E, Solcia E, Capella C, Sessa F, La Rosa S

Endocr Relat Cancer. 2015 Feb;22(1):35-45

Mid-gut ACTH-secreting neuroendocrine tumor unmasked with (18)F-dihydroxyphenylalanine-positron emission tomography.

Ducry J, Gomez F, Prior JO, Boubaker A, Matter M, Monti M, Pu Y, Pitteloud N, Portmann L

Endocrinol Diabetes Metab Case Rep. 2015;2015:140104

Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.

Uccella S, Sessa F, La Rosa S

Turk Patoloji Derg. 2015;31 Suppl 1:113-27

Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas.

Volante M, Monica V, Birocco N, Brizzi MP, Busso S, Daniele L, La Rosa S, Righi L, Sapino A, Berruti A, Scagliotti GV, Papotti M

Neuroendocrinology. 2015;101(2):151-60

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)–a phase II non-randomised trial.

Mitry E, Walter T, Baudin E, Kurtz JE, Ruszniewski P, Dominguez-Tinajero S, Bengrine-Lefevre L, Cadiot G, Dromain C, Farace F, Rougier P, Ducreux M

Eur J Cancer. 2014 Dec;50(18):3107-15

Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)–a phase II non-randomised trial.

Ducreux M, Dahan L, Smith D, O’Toole D, Lepère C, Dromain C, Vilgrain V, Baudin E, Lombard-Bohas C, Scoazec JY, Seitz JF, Bitoun L, Koné S, Mitry E

Eur J Cancer. 2014 Dec;50(18):3098-106

Gastric neuroendocrine neoplasms and related precursor lesions.

La Rosa S, Vanoli A

J Clin Pathol. 2014 Nov;67(11):938-48

Primary gastric Merkel cell carcinoma harboring DNA polyomavirus: first description of an unusual high-grade neuroendocrine carcinoma.

Capella C, Marando A, Longhi E, Bernasconi B, Finzi G, Parravicini C, Sessa F, La Rosa S

Hum Pathol. 2014 Jun;45(6):1310-4

The bright and fascinating world of the neuroendocrine cells.

Sessa F, Furlan D, Uccella S, Riva C, La Rosa S

Endocr Pathol. 2014 Jun;25(2):121-3

High-grade poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to proliferation and back.

La Rosa S, Sessa F

Endocr Pathol. 2014 Jun;25(2):193-8

Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

de Mestier L, Dromain C, d’Assignies G, Scoazec JY, Lassau N, Lebtahi R, Brixi H, Mitry E, Guimbaud R, Courbon F, d’Herbomez M, Cadiot G

Endocr Relat Cancer. 2014 Jun;21(3):R105-20

Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

Basturk O, Tang L, Hruban RH, Adsay V, Yang Z, Krasinskas AM, Vakiani E, La Rosa S, Jang KT, Frankel WL, Liu X, Zhang L, Giordano TJ, Bellizzi AM, Chen JH, Shi C, Allen P, Reidy DL, Wolfgang CL, Saka B, Rezaee N, Deshpande V, Klimstra DS

Am J Surg Pathol. 2014 Apr;38(4):437-47

Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland.

Gouffon M, Iff S, Ziegler K, Larche M, Schwarzenbach C, Prior JO, Matter M, Stettler C, Pralong FP

Swiss Med Wkly. 2014 Feb 19;144:w13924

Prognostic relevance of aberrant DNA methylation in g1 and g2 pancreatic neuroendocrine tumors.

Stefanoli M, La Rosa S, Sahnane N, Romualdi C, Pastorino R, Marando A, Capella C, Sessa F, Furlan D

Neuroendocrinology. 2014;100(1):26-34

Ectopic duodenal insulinoma: a very rare and challenging tumor type. Description of a case and review of the literature.

La Rosa S, Pariani D, Calandra C, Marando A, Sessa F, Cortese F, Capella C

Endocr Pathol. 2013 Dec;24(4):213-9

Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.

Vanoli A, La Rosa S, Luinetti O, Klersy C, Manca R, Alvisi C, Rossi S, Trespi E, Zangrandi A, Sessa F, Capella C, Solcia E

Hum Pathol. 2013 Sep;44(9):1827-37

Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.

La Rosa S, Marando A, Gatti G, Rapa I, Volante M, Papotti M, Sessa F, Capella C

Hum Pathol. 2013 Jul;44(7):1391-9

Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.

Sala E, Ferrante E, Verrua E, Malchiodi E, Mantovani G, Filopanti M, Ferrero S, Pietrabissa A, Vanoli A, La Rosa S, Zatelli MC, Beck-Peccoz P, Verga U

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):858-62

Images in endocrine pathology : oncocytic differentiation in a mixed adenoneuroendocrine carcinoma of the colon.

Marando A, Dainese E, La Rosa S, Capella C

Endocr Pathol. 2013 Mar;24(1):54-6

Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.

Furlan D, Sahnane N, Mazzoni M, Pastorino R, Carnevali I, Stefanoli M, Ferretti A, Chiaravalli AM, La Rosa S, Capella C

Virchows Arch. 2013 Jan;462(1):47-56